The U.S. Food and Drug Administration expanded the use of the antiviral drug Veklury (remdesivir) to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease. The previous guidelines limited the use of remdesivir to hospitalized adults and pediatric patients 12 years of age and older and weighing at least 40 kilograms … Continue reading FDA Expands Emergency Use Authorization of Remdesivir to Pediatric Patients Under 12 Years of Age